Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY AS A FUNCTIONAL ANTAGONIST FOR S1PR1 AND S1PR4
Document Type and Number:
WIPO Patent Application WO/2023/043024
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating Interstitial Fibrosis and Tubular Atrophy (IFTA) acting as a functional antagonist for S1PR1 and S1PR4 of S1P receptors, and more specifically, to a pharmaceutical composition including, as an active ingredient, a sphingolipid compound which does not cause cardiovascular side effects by acting as a functional antagonist for S1PR1 and S1PR4 and has an effect of preventing or treating Interstitial Fibrosis and Tubular Atrophy (IFTA).

Inventors:
LEE BONG YONG (KR)
PARK YANG HAE (KR)
KIM EUN JEONG (KR)
KIM HEE SUN (KR)
Application Number:
PCT/KR2022/010235
Publication Date:
March 23, 2023
Filing Date:
July 13, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NEXTGEN BIOSCIENCE (KR)
International Classes:
A61K31/4192; A61P13/12
Foreign References:
AU2018246796B22021-04-01
KR20170087813A2017-07-31
AU2019264073B22022-03-31
Other References:
TAYLOR MEADOWS KRISTEN R, STEINBERG MARCOS W, CLEMONS BRYAN, STOKES MATTHEW E, OPITECK GREGORY J, PEACH ROBERT, SCOTT FIONA L: "Ozanimod (RPC1063), a selective S1P R1 and S1P R5 modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus", PLOS ONE, vol. 13, no. 4, 2 April 2018 (2018-04-02), pages e0193236, XP093049726, DOI: 10.1371/journal.pone.0193236
INOUE T., YAO J, HUANG L, ROSIN D, ISHIHARA K, INAGI R, NANGAKU M, WADA Y, OKUSA M: "SAT-107 BONE MARROW STROMAL CELL ANTIGEN-1 MEDIATES ACUTE KIDNEY INJURY AND KIDNEY FIBROSIS", KIDNEY INTERNATIONAL REPORTS, vol. 4, no. 7, 1 July 2019 (2019-07-01), pages S50 - S51, XP093049730, DOI: 10.1016/j.ekir.2019.05.135
Attorney, Agent or Firm:
ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM et al. (KR)
Download PDF: